Corbion NV (CRBN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Corbion NV (CRBN) has a cash flow conversion efficiency ratio of 0.038x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€29.00 Million ≈ $33.90 Million USD) by net assets (€755.70 Million ≈ $883.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Corbion NV stock valuation for the company's overall valuation and market capitalisation.
Corbion NV - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Corbion NV's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Corbion NV Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Corbion NV ranked by their cash flow conversion efficiency. Explore Corbion NV (CRBN) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Delong Composite Energy Group Co Ltd
SHE:000593
|
0.009x |
|
Cansino Biologics Inc
SHG:688185
|
0.003x |
|
Zhonghong Pulin Medical Products Co. Ltd.
SHE:300981
|
-0.008x |
|
EFORT Intelligent Equipment Co Ltd
SHG:688165
|
-0.095x |
|
Smartgroup Corporation Ltd
AU:SIQ
|
0.253x |
|
Suzhou Chunqiu Electronic Technology Co Ltd Class A
SHG:603890
|
0.028x |
|
MannKind Corp
NASDAQ:MNKD
|
0.273x |
|
Innovita Biological Technology Co. Ltd. A
SHG:688253
|
N/A |
Annual Cash Flow Conversion Efficiency for Corbion NV (2002–2025)
The table below shows the annual cash flow conversion efficiency of Corbion NV from 2002 to 2025. View Corbion NV stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €742.60 Million ≈ $868.18 Million |
€160.90 Million ≈ $188.11 Million |
0.217x | -9.08% |
| 2024-12-31 | €772.50 Million ≈ $903.13 Million |
€184.10 Million ≈ $215.23 Million |
0.238x | -8.33% |
| 2023-12-31 | €636.20 Million ≈ $743.78 Million |
€165.40 Million ≈ $193.37 Million |
0.260x | +205.77% |
| 2022-12-31 | €625.70 Million ≈ $731.51 Million |
€53.20 Million ≈ $62.20 Million |
0.085x | +76.45% |
| 2021-12-31 | €554.10 Million ≈ $647.80 Million |
€26.70 Million ≈ $31.22 Million |
0.048x | -78.07% |
| 2020-12-31 | €516.00 Million ≈ $603.26 Million |
€113.40 Million ≈ $132.58 Million |
0.220x | +0.50% |
| 2019-12-31 | €529.10 Million ≈ $618.57 Million |
€115.70 Million ≈ $135.27 Million |
0.219x | +14.33% |
| 2018-12-31 | €520.20 Million ≈ $608.17 Million |
€99.50 Million ≈ $116.33 Million |
0.191x | -20.48% |
| 2017-12-31 | €489.30 Million ≈ $572.04 Million |
€117.70 Million ≈ $137.60 Million |
0.241x | -2.19% |
| 2016-12-31 | €498.50 Million ≈ $582.80 Million |
€122.60 Million ≈ $143.33 Million |
0.246x | +8.77% |
| 2015-12-31 | €487.80 Million ≈ $570.29 Million |
€110.30 Million ≈ $128.95 Million |
0.226x | +72.19% |
| 2014-12-31 | €508.70 Million ≈ $594.72 Million |
€66.80 Million ≈ $78.10 Million |
0.131x | +569.57% |
| 2013-12-31 | €504.80 Million ≈ $590.16 Million |
€9.90 Million ≈ $11.57 Million |
0.020x | -91.47% |
| 2012-12-31 | €858.70 Million ≈ $1.00 Billion |
€197.40 Million ≈ $230.78 Million |
0.230x | +47.30% |
| 2011-12-31 | €948.30 Million ≈ $1.11 Billion |
€148.00 Million ≈ $173.03 Million |
0.156x | -7.55% |
| 2010-12-31 | €1.12 Billion ≈ $1.31 Billion |
€188.60 Million ≈ $220.49 Million |
0.169x | -39.23% |
| 2009-12-31 | €997.80 Million ≈ $1.17 Billion |
€277.20 Million ≈ $324.08 Million |
0.278x | +165.57% |
| 2008-12-31 | €941.60 Million ≈ $1.10 Billion |
€98.50 Million ≈ $115.16 Million |
0.105x | -27.82% |
| 2007-12-31 | €957.70 Million ≈ $1.12 Billion |
€138.80 Million ≈ $162.27 Million |
0.145x | -31.13% |
| 2006-12-31 | €844.90 Million ≈ $987.78 Million |
€177.80 Million ≈ $207.87 Million |
0.210x | -76.09% |
| 2005-12-31 | €946.40 Million ≈ $1.11 Billion |
€833.00 Million ≈ $973.86 Million |
0.880x | +254.75% |
| 2004-12-31 | €806.50 Million ≈ $942.88 Million |
€200.10 Million ≈ $233.94 Million |
0.248x | -42.04% |
| 2003-12-31 | €778.10 Million ≈ $909.68 Million |
€333.10 Million ≈ $389.43 Million |
0.428x | +60.94% |
| 2002-12-31 | €739.10 Million ≈ $864.09 Million |
€196.60 Million ≈ $229.85 Million |
0.266x | -- |
About Corbion NV
Corbion N.V. provides lactic acid and derivatives, food preservation solutions, functional ingredient systems, and algae-derived nutritional ingredients in the Netherlands, the United States, Asia, rest of Americas, the rest of Europe, the Middle East, and Africa. It operates in two segments, Functional Ingredients & Solutions, and Health & Nutrition. The company offers antioxidants, fermentation… Read more